首页> 外文期刊>Pediatric dentistry >Effect of FDA Warning on Codeine and Alternate Opioid Prescribing After Pediatric Dental Procedures in Ohio
【24h】

Effect of FDA Warning on Codeine and Alternate Opioid Prescribing After Pediatric Dental Procedures in Ohio

机译:FDA警告对俄亥俄州小儿牙科手术后的可待因和交替阿片类药物的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: Evaluate changes in codeine and alternate opioid prescription filling after pediatric dental procedures associated with the FDA's codeine black box warning for tonsillectomy/adenoidectomy. Methods: Patients aged 0-17 years who underwent any toothextraction or restorative procedure during August 2011-August 2016 were identified in Ohio Medicaid claims. Interrupted time series analyses were used to evaluate the impact of the FDA's warning on the rates of codeine or alternative opioid prescription fills within 14 days postprocedure.Results: In August 2011, codeine and alternative opioid prescription fills rates after a dental procedure were 2.3 percent and 3.3 percent, respectively. These rates decreased monthly by 0.02 and 0.01 percent, respectively during the study period (PConclusions: Opioid prescription filling after pediatric dental procedures decreased between 2011 and 2016 among Medicaid beneficiaries. In addition, there was a significant immediate reduction incodeine prescription filling after the FDA's codeine black box warning for tonsillectomy/adenoidectomy.
机译:目的:评估与FDA的Codeine黑盒警告相关的儿科牙科手术后的可待因和交替阿片类药物处方填充的变化,用于扁桃体切除术/腺体切除术。方法:在2011年8月2011年8月至2016年8月期间进行了0-17岁的患者在俄亥俄州医疗补助索赔中确定。中断的时间序列分析用于评估FDA在14天内对可待因或替代阿片类药物处方填充率的影响的影响。结果:在2011年8月,牙科手术患者填补率为2.3%后填补率分别为3.3%。这些利率分别在研究期间每月减少0.02%和0.01%(PCONCLUSIONS:在医疗补助受益者中,2011年间儿科牙科手术填充的阿片类药物填充物)。此外,FDA的可待因后,在FDA的可待因下会有一个显着的直接降低卷入的难题黑匣子警告扁桃体切除术/腺样肌瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号